: AstraZeneca’s new COVID-19 vaccine trial data will give the shot a U.S. boost


The COVID-19 vaccine of the U.K.-Swedish pharmaceuticals group AstraZeneca has shown robust results in its U.S. trial, the company said on Monday.

: New CDC school guidelines could mean more kids in classrooms — and more financial stability for parents

Previous article

TaxWatch: Attention: Here’s one important tax deadline that has NOT been delayed

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News